Co-Hosts

Yao Yuan
POLSKY
SAPA

Conference Chair

Dr. Gui-Dong Zhu

President, Yao Yuan—Academy for Pharma Innovation; CEO, Sparx Therapeutics, Inc.

Symposium Steering Committee

Scott Brun, MD
Ex-Vice President, AbbVie, Former Head of AbbVie Ventures
Ka Yee Lee, Ph.D
Vice Provost for Research, Professor in Chemistry, the James Franck Institute, Institute for Biophysical Dynamics and the College, University of Chicago
Bala Srinivasan, Ph.D
Vice President for Strategy and Innovation and Chief International Officer, The University of Chicago
Gui-Dong Zhu, Ph.D
President, Yao Yuan—Academy for Pharma Innovation; CEO, Sparx Therapeutics, Inc.

Speakers

Keynote Bio-Partnering

Chad A Mirkin, Ph.D

George B. Rathmann Professor, Northwestern University; Member of All Three US National Academies, President’s Council of Advisors on Science & Technology (Obama Administration)

Alexis Borisy, Ph.D

Managing Partner, Third Rock Ventures, Chairman of Celsius Therapeutics、Tango Therapeutics、Relay Therapeutics

Bala Srinivasan, Ph.D

Vice President for Strategy and Innovation, Chief International Officer, Deputy Provost, The University of Chicago

Scientific Symposium​

Matthew Tirrell, Ph.D

Dean and Founding Pritzker Director of the Institute for Molecular Engineering, The University of Chicago

Alan Huang, Ph.D

CSO, Tango Therapeutics

Brian Blagg, Ph.D

Charles Huisking Professor of Chemistry and Biochemistry, University of Notre Dame

Bin Zhang, MD, PhD

Professor of Medicine, School of Medicine, Northwestern University

Lyu Aiping, Ph.D

Dean and Kennedy Y.H. Wong Professor, Hong Kong Baptist University , School of Chinese Medicine

Thomas von Geldern, Ph.D

President, Embedded Consulting

Program Highlights

Keynote Presentations

Dr. Chad A Mirkin, Ph.D, George B. Rathmann Professor, Northwestern University 

Dr. Alexis Borisy, Ph.D, Managing Partner, Third Rock Ventures

Bala Srinivasan, Ph.D, Vice President , The University of Chicago

Dr. Matthew Tirrell, Ph.D, Dean and Founding Pritzker Director of the Institute for Molecular Engineering, The University of Chicago

Dr. Brian Blagg, Ph.D, Charles Huisking Professor of Chemistry and Biochemistry, University of Notre Dame

Dr. Lyu Aiping, Dean and Kennedy Y.H. Wong Professor, Hong Kong Baptist University , School of Chinese Medicine

Up to 50

Renowned Venture Capitals and Investment Banks

Up to 50

Roadshow Presentations

Bio-partnering

And Matchmaking Activities

Scientific Symposium

Program Introduction
and Key Initiatives

Tentative Agenda

If you can’t read clearly, please download a PDF version:

DateTimeEvent
29
May
2019

(Wednesday)

06:00 PM – 08:30 PMVIP dinner for speakers and invited guests (Venue: TBD)
30
May
2019

(Thursday) Bio- Partnering Forum

08:30 AM – 08:45 AM

Welcome and Opening Remarks:

Gui-Dong Zhu,
Ph.D, President, Yao Yuan & CEO, Sparx Therapeutics

08:45 AM – 09:00 AMSpecial Remarks: TBD
09:00 AM – 10:00 AM

Keynote Address (1)

Chad A Mirkin, Ph.D
George B. Rathmann Professor, Northwestern University

10:00 AM – 10:20 AMBreak & Networking
10:20 AM – 12:00 AMRoad Show Session (2-3 Tracks)
12:00 PM – 01:20 PM

Lunch w/Keynote Address (2,3)

Bala Srinivasan, Ph.D
Vice President , The University of Chicago

Alexis Borisy, Ph.D
Managing Partner, Third Rock Ventures

01:20 PM – 03:00 PMRoad Show Session (2-3 Tracks)
03:00 PM – 03:20 PMCoffee Break & Bio-Partnering
03:20 PM – 05:50 PMRoad Show Session (2-3 Tracks)
05:40 PM – 05:50 PMClosing remarks for Bio-Partnering Forum
05:50 PM  08:30 PMNetworking & Bio-Partnering Reception (Food and beverage served ) Sparx Therapeutics (700 E. Business Center Dr., Mt Prospect, IL 60056)
31
May
2019

(Friday) Scientific Symposium

08:30 AM – 08:40 AMWelcome & Opening Remarks
08:40 AM – 09:20 AM

Symposium Keynote Address (1)

Dr. Matthew Tirrell,
Dean and Founding Pritzker Director of the Institute for Molecular Engineering, The University of Chicago

09:20 AM – 10:00 AM

Symposium Keynote Address (2)

Dr. Alan Huang,
CSO, Tango Therapeutics

10:00 AM – 10:20 AMBreak & Networking
10:20 AM – 11:00 AM

Symposium Keynote Address (3)

Dr. Brian Blagg,
Charles Huisking Professor of Chemistry and Biochemistry, University of Notre Dame

11:00 AM – 11:40 AM

Symposium Keynote Address (4)

Dr. Lyu Aiping,
Dean and Kennedy Y.H. Wong Professor, Hong Kong Baptist University , School of Chinese Medicine

11:40 AM – 01:00 PMLunch & Job Fair Presentations
01:00 PM – 01:40 PM

Symposium Keynote Address (5)

Bin Zhang, MD, PhD,
Professor of Medicine, School of Medicine, Northwestern University

01:40 PM – 02:20 PM

Symposium Keynote Address (6)

Dr. Thomas von Geldern,
President, Embedded Consulting

02:20 PM – 05:30 PMClosing Remark and Job Fair

Projected Attendees

Participating Venture Capital

1. Third Rock Partners
2. AbbVie Ventures
3. Hillhouse Capital Group
4. Sangel Capital

5. Oceanpine Healthcare Fund
6. VI Ventures
7. Good Health Capital
8. Sunforest Capital

9. Yuanming Capital
10. Bioventure
11. Good AI Capital

Participating Startups / Small Cap Biotech

Huddle for Warmth, Building a Global Leading Biomedical Hub in Midwestern America

When most people think about “Midwestern America”, they associate images of flat plains and sprawling farmlands, but surprisingly not many think of the incredible skylines of Chicago. Today “America’s Heartland” is evolving at an ever increasing rate. Not only was Chicago named the best city to live in by several magazines, but also the Midwest is emerging as one of the top global hubs for biomedical innovation – a healthy ecosystem for biotech research.

Within the heart of this ecosystem lies an incredible pool of talent, which has driven tremendous progress on fundamental research and applied life sciences. Their hard work and efforts have translated into numerous life-changing medicines. This is in large part a testament to the top- notch institutions in the area such as the University of Chicago, Northwestern University, University of Illinois, University of Wisconsin, University of Michigan , and Washington University in St. Louis, among many others that place immense emphasis on strong life-science related research. The surrounding large cap pharmaceutical companies such as AbbVie, Abbott, Baxter, and Eli Lilly contribute research muscle as well as business and management expertise, an essential foundation to this hub.

That being said, scientific accomplishments and large pools of talent are necessary but not sufficient in building an ideal ecosystem for the biotech community, particularly when compared to Boston and the Bay area. To attract early stage venture capital resources and foster an environment that supports innovative startups, we need to “Huddle for Warmth”. What that means is building in all the other factors required for fostering fast-paced growth and development to become the leading global hub for biomedical innovation. The academic institutions and industry researchers need to have a more interwoven, productive, and sustainable form of collaboration. We’re looking for more support from clinical research and development, regulatory affairs, business development, commercial/financial experts, and even a strong voice in the realm of government & politics. This conference attempts to dial in all the resources and connections to help generate the synergy which will fuel this wealthy ecosystem of scientific advancement. This would establish the framework to effectively translate groundbreaking discoveries to enviable assets that are attractive to capitals around the world, including China.

Date & Venue

Renaissance Schaumburg Convention Center Hotel (1551 Thoreau Dr., Schaumburg, IL 60173, USA)

THE 11TH YAO YUAN CONFERENCE

PHOTO GALLERY